COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING
TORONTO, ONTARIO, Oct. 19, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) is pleased to announce the publication of a new corporate presentation, now available on its website at www.cosciensbio.com. The presentation provides an overview of the Company and its operating subsidiaries, following the recent acquisition of Nualtis […]
COSCIENS has announced an update regarding its corporate presentation and a convertible debenture offering. The company's executives anticipate additional sales as part of the Offering, which will contribute to the pro forma market capitalization and cash position of COSCIENS. These forward-looking statements are given in accordance with the "safe harbour" provisions of applicable securities legislation.
Written by urgent.news from Financial Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
